Epstein Becker Green

About the Authors: Bradley Merrill Thompson is a member of the firm at Epstein Becker & Green, P.C. There, he counsels medical device, drug, and combination product companies on a wide range of FDA regulatory issues.  Chris Bergstrom is a digital health leader, for The Boston Consulting Group (BCG). At BCG, he directs digital health initiatives across large payer, provider, med tech, and bio/...
By Dave Muoio October 18, 2017
As telehealth becomes more prevalent among US healthcare institutions, states are rolling out or modifying their laws to better define regulatory frameworks specifically affecting remote delivery of care. In fact, every state but Connecticut and Massachusetts has made substantive legal changes to how telehealth is delivered in the past year, with some taking specific actions to better define the...
By Jonah Comstock September 1, 2017
Computers, whether through simple decision trees or complex neural networks, are increasingly playing a larger and larger role in helping healthcare providers make treatment decisions. As the role of clinical decision software in healthcare grows, so too does the need for guidelines that allow clinicians and patients to trust and understand that software. This week, the CDS Coalition, an industry...
By Jonah Comstock December 1, 2014
Bradley Merrill Thompson testifying before Congress last year. Bradley Merrill Thompson, a partner at Epstein Becker Green who specializes in consulting with mobile health startups about FDA clearance, is launching a new venture called Aventor that aims to bring discounted regulatory consulting and advocacy services to companies that use mobile health and connected health to help the poor. "In...